Citadel Advisors - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365A901. A total of 2 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2015$2,000
-80.0%
2,000
-77.3%
0.00%
Q3 2015$10,000
-81.1%
8,800
-67.9%
0.00%
Q2 2015$53,000
+2550.0%
27,400
+2390.9%
0.00%
Q1 2015$2,000
+100.0%
1,100
+120.0%
0.00%
Q4 2014$1,000
-94.7%
500
-93.6%
0.00%
Q3 2014$19,000
+111.1%
7,800
+225.0%
0.00%
Q2 2014$9,0000.0%2,400
+26.3%
0.00%
Q1 2014$9,000
-73.5%
1,900
-78.2%
0.00%
Q4 2013$34,000
-12.8%
8,700
+1.2%
0.00%
Q3 2013$39,000
+62.5%
8,600
+75.5%
0.00%
Q2 2013$24,0004,9000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2013
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 7,100$35,0000.00%
Citadel Advisors 4,900$24,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders